Zoetis (ZTS) Accumulated Expenses (2012 - 2026)
Zoetis (ZTS) reported Accumulated Expenses of $239.0 million for Q1 2026, down 17.87% year-over-year from $291.0 million in Q1 2025, and down 40.4% quarter-over-quarter from $401.0 million in Q4 2025.
Zoetis (ZTS) Accumulated Expenses (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has 15 years of Accumulated Expenses data on file, last reported at $239.0 million in Q1 2026.
- Accumulated Expenses for Q1 2026 came in at $239.0 million, down 17.87% year-over-year; the trailing twelve-month figure through Mar 2026 was $239.0 million (down 17.87% YoY), and the FY2025 annual result was $401.0 million, down 46.25% from the prior year.
- Accumulated Expenses retreated to $239.0 million in Q1 2026 per ZTS's latest filing, from $401.0 million in the prior quarter.
- Over five years, Accumulated Expenses peaked at $746.0 million in Q4 2024 and troughed at $232.0 million in Q1 2023.
- A 5-year average of $335.8 million and a median of $284.0 million in 2023 frame the typical range for Accumulated Expenses.
- The sharpest annual moves came in 2022 and 2023: Accumulated Expenses sank 57.75% in 2022, then surged 127.67% in 2023.
- A 5-year view of Accumulated Expenses shows it stood at $300.0 million in 2022, then surged by 127.67% to $683.0 million in 2023, then grew by 9.22% to $746.0 million in 2024, then plunged by 46.25% to $401.0 million in 2025, then slumped by 40.4% to $239.0 million in 2026.
- Business Quant data shows ZTS's Accumulated Expenses at $239.0 million in Q1 2026, $401.0 million in Q4 2025, and $337.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 239.00 Mn |
| Dec 31, 2025 | 401.00 Mn |
| Sep 30, 2025 | 337.00 Mn |
| Jun 30, 2025 | 293.00 Mn |
| Mar 31, 2025 | 291.00 Mn |
| Dec 31, 2024 | 746.00 Mn |
| Sep 30, 2024 | 335.00 Mn |
| Jun 30, 2024 | 276.00 Mn |
| Mar 31, 2024 | 272.00 Mn |
| Dec 31, 2023 | 683.00 Mn |
| Sep 30, 2023 | 284.00 Mn |
| Jun 30, 2023 | 247.00 Mn |
| Mar 31, 2023 | 232.00 Mn |
| Dec 31, 2022 | 300.00 Mn |
| Sep 30, 2022 | 257.00 Mn |
| Jun 30, 2022 | 237.00 Mn |
| Mar 31, 2022 | 278.00 Mn |
| Dec 31, 2021 | 710.00 Mn |
| Sep 30, 2021 | 314.00 Mn |
| Jun 30, 2021 | 239.00 Mn |